Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Challenge: Expanding the immuno-oncology footprint

Oxford researchers are investigating the evolution of the three-way conversation between cancer cells, stromal elements and immune cells from before the first immune-sensing events in precancerous states, during tumorigenesis, and under therapeutic pressure. By analysing clinical samples, murine models (in partnership with the collaborators at Glasgow and Edinburgh) and complex co-culture systems, they aim to discover the TIME contexts predictive of response in GI cancers and understand why CD8+ infiltration is not universally predictive of therapeutic response nor prognosis.